Migraine Therapeutics Market by Product, Treatment, and Geography - Forecast and Analysis 2021-2025

1 Executive Summary

2 Market Landscape

• 2.1 Market ecosystem
  • Exhibit 01: Parent market

• 2.2 Market characteristics
  • Exhibit 02: Market characteristics

• 2.3 Value chain analysis
  • Exhibit 03: Value chain analysis: Pharmaceuticals market

3 Market Sizing

• 3.1 Market definition
  • Exhibit 04: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
  • Exhibit 05: Market segments

• 3.3 Market size 2020

• 3.4 Market outlook: Forecast for 2020 - 2025
  • Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
  • Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
  • Exhibit 08: Five forces analysis 2020 & 2025

• 4.2 Bargaining power of buyers
  • Exhibit 09: Bargaining power of buyers

• 4.3 Bargaining power of suppliers
  • Exhibit 10: Bargaining power of suppliers

• 4.4 Threat of new entrants
  • Exhibit 11: Threat of new entrants

• 4.5 Threat of substitutes
  • Exhibit 12: Threat of substitutes

• 4.6 Threat of rivalry
  • Exhibit 13: Threat of rivalry

• 4.7 Market condition
  • Exhibit 14: Market condition - Five forces 2020

5 Market Segmentation by Product

• 5.1 Market segments
  • Exhibit 15: Product - Market share 2020-2025 (%)

• 5.2 Comparison by Product
  • Exhibit 16: Comparison by Product

• 5.3 Drugs - Market size and forecast 2020-2025
  • Exhibit 17: Drugs - Market size and forecast 2020-2025 ($ million)
  • Exhibit 18: Drugs - Year-over-year growth 2020-2025 (%)

• 5.4 Devices - Market size and forecast 2020-2025
  • Exhibit 19: Devices - Market size and forecast 2020-2025 ($ million)
  • Exhibit 20: Devices - Year-over-year growth 2020-2025 (%)

• 5.5 Market opportunity by Product
  • Exhibit 21: Market opportunity by Product

6 Market Segmentation by Treatment

• 6.1 Preventive treatment

• 6.2 Abortive treatment

7 Customer landscape

8 Geographic Landscape

• 8.1 Geographic segmentation

• 8.2 Geographic comparison

• 8.3 North America - Market size and forecast 2020-2025

• 8.4 Europe - Market size and forecast 2020-2025

• 8.5 Asia - Market size and forecast 2020-2025

• 8.6 ROW - Market size and forecast 2020-2025

• 8.7 Key leading countries

• 8.8 Market opportunity by geography

9 Drivers, Challenges, and Trends

• 9.1 Market drivers

• 9.2 Market challenges

• 9.3 Market trends

10 Vendor Landscape

• 10.1 Vendor landscape

• 10.2 Landscape disruption

• 10.3 Competitive scenario

11 Vendor Analysis

• 11.1 Vendors covered

• 11.2 Market positioning of vendors

• 11.3 AbbVie Inc.

• 11.4 Amgen Inc.

• 11.5 Eli Lilly and Co.

• 11.6 eNeura Inc.

• 11.7 GlaxoSmithKline Plc

• 11.8 Grunenthal GmbH

• 11.9 H. Lundbeck AS

• 11.10 Pfizer Inc.

• 11.11 Teva Pharmaceutical Industries Ltd.

• 11.12 Upsher-Smith Laboratories LLC

12 Appendix

• 12.1 Scope of the report

• 12.2 Currency conversion rates for US$

• 12.3 Research methodology

• 12.4 List of abbreviations